Andrew Komjathy

Entity
Individual
Business address
Catabasis Pharmaceuticals, Inc., One Kendall Square, Suite B14202, 02139 Cambridge, MA
Signature Ownership
/s/ Ben Harshbarger, as attorney-in-fact for Andrew Komjathy
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Andrew Komjathy has filed 10 SEC EDGAR filings since 9/19/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 25, 2025 Mar 21, 2025 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT Feb 12, 2024 Feb 8, 2024 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 6, 2023 Jun 2, 2023 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 3, 2022 Mar 1, 2022 001-37467
5 Open Document Open Filing OWNERSHIP DOCUMENT Feb 10, 2022 Dec 28, 2021 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT Nov 23, 2021 Nov 19, 2021 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 2, 2021 Jun 2, 2021 001-37467
4 Open Document Open Filing FORM 4 - Feb 14, 2020 Feb 12, 2020 001-37467
4 Open Document Open Filing FORM 4 - Sep 19, 2019 Sep 18, 2019 001-37467
3 Open Document Open Filing FORM 3 - Sep 19, 2019 Sep 18, 2019 001-37467